Oral ambroxol increases brain glucocerebrosidase activity in a nonhuman primate. (2017)

First Author: Migdalska-Richards A
Attributed to:  Targeting glucocerebrosidase for disease-modifying treatments in Parkinson's disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/syn.21967

PubMed Identifier: 28295625

Publication URI: http://europepmc.org/abstract/MED/28295625

Type: Journal Article/Review

Volume: 71

Parent Publication: Synapse (New York, N.Y.)

Issue: 7

ISSN: 0887-4476